Lyophilized Drugs Market Size Is Projected to Reach US$ 560.2 Billion at a CAGR Of 7.1% By 2027 | Sanofi S.A, Merck & Co., Fresenius Kabi USA,

Lyophilization is a process of removing any moisture from the drug to chemically stabilize the drug after sealing. Lyophilization is done to enhance the shelf-life of the drug and offer easy transportation of bulk drugs. Moreover, the lyophilized drug can be also be stored at room temperature. Manufacturers such as BUCHI Labortechnik AG, SP Scientific, and West Pharmaceutical Services, Inc. are focusing on the development of the lyophilization process to enhance the production capacity of lyophilized drugs. Moreover, pharmaceutical companies are increasing their focus on the production of highly advanced lyophilized drug delivery systems, to meet significant challenges such as multistep drug administration procedures, inconvenience administration of drugs through self-injection, risk of needlestick injuries, and others (lengthy dose preparation timings).

The global lyophilized drugs market is projected to be valued at US$ 322.9 Billion in 2018 and is expected to witness a CAGR of 7.1% during the forecast period (2018–2026).

𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐢𝐧𝐠 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐚𝐩𝐩𝐫𝐨𝐯𝐚𝐥𝐬 𝐟𝐨𝐫 𝐥𝐲𝐨𝐩𝐡𝐢𝐥𝐢𝐳𝐞𝐝 𝐝𝐫𝐮𝐠𝐬 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐟𝐮𝐞𝐥 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐥𝐲𝐨𝐩𝐡𝐢𝐥𝐢𝐳𝐞𝐝 𝐝𝐫𝐮𝐠𝐬 𝐦𝐚𝐫𝐤𝐞𝐭

Rising regulatory approvals for a wide range of lyophilized drugs is projected to fuel the growth of the lyophilized drugs market. For instance, in April 2014, GlaxoSmithKline plc received the U.S. Food and Drug Administration (FDA) approval for its Tanzeum (albiglutide lyophilized for injection), for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Moreover, in September 2014, the U.S. Food and Drug Administration (FDA) approved a new formulation of Abilify Maintena (aripiprazole) for extended-release injectable suspension, a prefilled dual-chamber syringe, developed by Otsuka Pharmaceutical Development & Commercialization, Inc. The drug is indicated for the treatment of schizophrenia in adults and in the maintenance of monotherapy treatment of bipolar I disorder in adults

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/2930

Furthermore, rising initiatives by key players such as acquisitions for advancement and distribution of anesthetics to various healthcare organizations is further projected to significantly fuel the market growth of lyophilized drugs. For instance, in December 2018, North American Partners in Anesthesia (NAPA), single-specialty anesthesia and perioperative management firm in the U.S., acquired certain assets of Aisthesis Partners in anesthesia care and its affiliated medical practices (‘Aisthesis’). Aisthesis provides its anesthesia services to 25 ambulatory surgical centers (ASCs), 3 hospitals, and 3 physician offices across four states in the U.S. and the District of Columbia.

𝐌𝐚𝐫𝐤𝐞𝐭 - 𝐑𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬

On the other hand, an increasing product recalls for lyophilized drugs and packaging type is expected to curb the market growth. In January 2019, U.S. Food and Drug Administration issued a product recall notice for three lots of Vecuronium Bromide for Injection, 10 mg (lyophilized powder), and a lot of Vecuronium Bromide for Injection, 20 mg (lyophilized powder), developed by Sun Pharmaceutical Industries, Inc. The product has been recalled due to the presence of glass particulate in the product.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

North America is projected to witness lucrative growth in the global lyophilized drugs market, and this can be attributed to growing prevalence of diseases in the U.S. Moreover, strong presence of key manufacturers such as Fresenius Kabi, Merck & Co. Inc., and Amneal Pharmaceutical who are extensively engaged in manufacturing of lyophilized injectable is contributing to growth of the North America Lyophilized Drugs market. Moreover, rising product approvals by regulatory authorities in North America is also projected to foster the growth of North America Lyophilized Drugs Market. For instance, in December 2015, Aurobindo Pharma Limited received the U.S. FDA approval to manufacture and market Methylprednisolone Sodium Succinate Injection USP (lyophilized drug), 40 mg/vial, 125 mg/vial, 500 mg/vial, and 2 g/vial.

𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/2930

The Asia Pacific is also projected to fuel the growth of the global lyophilized drugs market, due to increasing initiatives by key players to expand their production facility, in order to enhance the production of lyophilized drugs on a large scale. For instance, in July 2017, Alembic Pharmaceuticals, based in India, opened its new manufacturing facility in Panelav, Gujarat, India. The new site has a manufacturing capacity of around 20 million vials of liquid injectable and lyophilized concentrations.

Europe is projected to experience growth due to continuous advancements in lyophilization processes and rising launches of lyophilized drugs. For instance, in April 2017, BÜCHI Labortechnik AG introduced the modular Lyovapor platform for freeze-drying (lyophilization). The new product offers continuous sublimation.

Key players operating in the global lyophilized drugs market include 𝗦𝗮𝗻𝗼𝗳𝗶 𝗦.𝗔, 𝗠𝗲𝗿𝗰𝗸 & 𝗖𝗼., 𝗜𝗻𝗰., 𝗙𝗿𝗲𝘀𝗲𝗻𝗶𝘂𝘀 𝗞𝗮𝗯𝗶 𝗨𝗦𝗔, 𝗟𝗟𝗖., 𝗖𝗶𝗿𝗼𝗻 𝗗𝗿𝘂𝗴𝘀 & 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀 𝗣𝘃𝘁 𝗟𝘁𝗱., 𝗚𝗹𝗮𝘅𝗼𝗦𝗺𝗶𝘁𝗵𝗞𝗹𝗶𝗻𝗲 𝗽𝗹𝗰., 𝗠𝘆𝗹𝗮𝗻 𝗡𝗩., 𝗣𝗳𝗶𝘇𝗲𝗿, 𝗜𝗻𝗰., 𝗔𝗺𝗻𝗲𝗮𝗹 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀 𝗟𝗟𝗖, 𝗢𝘁𝘀𝘂𝗸𝗮 𝗛𝗼𝗹𝗱𝗶𝗻𝗴𝘀 𝗖𝗼., 𝗟𝘁𝗱. (𝗢𝘁𝘀𝘂𝗸𝗮 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗖𝗼., 𝗟𝘁𝗱.), 𝗮𝗻𝗱 𝗕𝗧𝗚 𝗣𝗹𝗰.

Detailed Segmentation:

• Global Lyophilized Drugs Market, By Drug Class:

o Anti-infective
o Antineoplastic
o Diuretics
o Proton Pump Inhibitor
o Anesthetic
o Anticoagulant
o NSAID’s
o Others

• Global Lyophilized Drugs Market, By Indication:

o Infectious Disease
o Autoimmune Disease
o Gastrointestinal Disease
o Cancer
o Others

• Global Lyophilized Drugs Market, By Packaging Type:

o Vial
o Injection
o Cartridge

𝐓𝐨 𝐆𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐇𝐞𝐫𝐞 @ https://www.coherentmarketinsights.com/insight/request-pdf/2930

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About US:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.